Model Medicines, Inc.
Other · San Deigo, California
Model Medicines, Inc. is a other company based in San Deigo, California, incorporated in 2019. It has reported $22.5 million raised across 4 Form D filings with the SEC, most recently in 2025.
Model Medicines engineers first-in-class small molecules against biological choke points, using AI to advance pipeline-in-a-pill therapeutics across high-impact diseases.
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2025-11-14 | — | $3.3M | $22.5M | SEC Form D | |
| 2024-10-15 | — | $14.8M | $19.2M | SEC Form D | |
| 2024-02-07 | — | $950K | $4.5M | SEC Form D | |
| 2021-11-09 | — | $3.5M | $3.5M | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.